Antithrombotic Adventures: Unveiling Special Populations

Balancing the prevention of thrombosis while minimizing bleeding risk is a major challenge when multiple indications exist for antiplatelet and anticoagulant drugs. This expert talk provides guidance on optimal therapy to improve outcomes, including time-limited triple therapy, preference for NOACs over VKAs, and anticoagulant monotherapy when feasible. This insightful session will aid medical professionals in weighing the thrombotic and bleeding risks when determining the appropriate... Read more